Enlivex Therapeutics Stock (NASDAQ: ENLV) stock price, news, charts, stock research, profile.
Open | $1.240 |
Close | $1.270 |
Volume / Avg. | 51.526K / 169.633K |
Day Range | 1.240 - 1.300 |
52 Wk Range | 1.150 - 4.590 |
Market Cap | $23.633M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 25 |
Short Interest | 1.36% |
Days to Cover | 2.52 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Enlivex Therapeutics (NASDAQ: ENLV) through any online brokerage.
There are no as such competitors for Enlivex Therapeutics.
The latest price target for Enlivex Therapeutics (NASDAQ: ENLV) was reported by HC Wainwright & Co. on Friday, April 12, 2024. The analyst firm set a price target for 7.00 expecting ENLV to rise to within 12 months (a possible 450.88% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Enlivex Therapeutics (NASDAQ: ENLV) is $1.2707 last updated April 22, 2024 at 5:43 PM EDT.
There are no upcoming dividends for Enlivex Therapeutics.
Enlivex Therapeutics’s Q4 earnings are confirmed for Friday, March 29, 2024.
There is no upcoming split for Enlivex Therapeutics.
Enlivex Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.